Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard C. Becker

Showing results (31-40 of 329) with videos related to

Pageof 33
Sort By:
American Heart Journal|December 9, 2003
Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studiesRobert J Kim, Richard C Becker
Thrombosis and Haemostasis|February 6, 2010
Platelet P2Y12 receptor antagonist pharmacokinetics and pharmacodynamics: A foundation for distinguishing mechanisms of bleeding and anticipated risk for platelet-directed therapiesRichard C Becker, Paul A Gurbel
Journal of Thrombosis and Thrombolysis|July 18, 2013
The pharmacology of novel oral anticoagulantsTracy A DeWald, Richard C Becker
Journal of Thrombosis and Thrombolysis|January 24, 2013
Oral anticoagulants in older adults with atrial fibrillationGwen M Bernacki, Richard C Becker
Current Atherosclerosis Reports|March 26, 2014
Pharmacogenetics of antiplatelet therapyPatrick L Daly, Richard C Becker
Platelets|July 15, 2009
A clinician's perspective of emerging P2Y(12)-directed pharmacotherapies, ex vivo measurement tools, and clinical outcomesJeffrey S Berger, Richard C Becker
Current Treatment Options in Cardiovascular Medicine|March 8, 2008
Identification and treatment of arterial thrombophiliaMark Y Chan, Richard C Becker
Critical Pathways in Cardiology|May 19, 2012
A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillationJames W Wisler, Richard C Becker
Cardiology in Review|April 10, 2023
Cardiopulmonary Phenotypes of Post Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2: A Narrative ReviewMuhammad H Khan, Richard C Becker
Journal of Thrombosis and Thrombolysis|April 15, 2024
Factor XI: structure, function and therapeutic inhibitionAhmed E Ali, Richard C Becker
Pageof 33

Showing results (31-40 of 329) with videos related to

Sort By:
Pageof 33
American Heart Journal|December 9, 2003
Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studiesRobert J Kim, Richard C Becker
Thrombosis and Haemostasis|February 6, 2010
Platelet P2Y12 receptor antagonist pharmacokinetics and pharmacodynamics: A foundation for distinguishing mechanisms of bleeding and anticipated risk for platelet-directed therapiesRichard C Becker, Paul A Gurbel
Journal of Thrombosis and Thrombolysis|July 18, 2013
The pharmacology of novel oral anticoagulantsTracy A DeWald, Richard C Becker
Journal of Thrombosis and Thrombolysis|January 24, 2013
Oral anticoagulants in older adults with atrial fibrillationGwen M Bernacki, Richard C Becker
Current Atherosclerosis Reports|March 26, 2014
Pharmacogenetics of antiplatelet therapyPatrick L Daly, Richard C Becker
Platelets|July 15, 2009
A clinician's perspective of emerging P2Y(12)-directed pharmacotherapies, ex vivo measurement tools, and clinical outcomesJeffrey S Berger, Richard C Becker
Current Treatment Options in Cardiovascular Medicine|March 8, 2008
Identification and treatment of arterial thrombophiliaMark Y Chan, Richard C Becker
Critical Pathways in Cardiology|May 19, 2012
A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillationJames W Wisler, Richard C Becker
Cardiology in Review|April 10, 2023
Cardiopulmonary Phenotypes of Post Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2: A Narrative ReviewMuhammad H Khan, Richard C Becker
Journal of Thrombosis and Thrombolysis|April 15, 2024
Factor XI: structure, function and therapeutic inhibitionAhmed E Ali, Richard C Becker
Pageof 33